CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 174576-174734 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/ee0a7632371a08727d41e55aad7d621daeceef7d","sourcedb":"CORD-19","sourceid":"ee0a7632371a08727d41e55aad7d621daeceef7d","text":"Of the 20 patients with concomitant mutations, 6/20 (30%) had NRAS Gly12Ser mutations, compared to 3/56 (5%) patients with a single RAS mutation (p = 0.0084).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T54578","span":{"begin":0,"end":158},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T54578","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T422","span":{"begin":0,"end":158},"obj":"Sentence"}],"attributes":[{"subj":"T422","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93d1ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ebec93"}]}]}}